FIRE1 Competitors and Similar CompaniesClear all

FIRE1's competitors and similar companies include Decibel Therapeutics, ReShape Lifesciences, BioCardia and ElectroCore.
FIRE1
FIRE1
FIRE1 focuses on developing novel remote monitoring devices.
Decibel Therapeutics
Decibel Therapeutics
Decibel Therapeutics is a biotechnology company that discovers and develops transformative treatments to restore and improve hearing and balance.
ReShape Lifesciences
ReShape Lifesciences
ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.
BioCardia
BioCardia
BioCardia is a clinical-stage regenerative medicine company.
ElectroCore
ElectroCore
ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.
Founding Date
Founding Date
N/A
Founding Date
2015
Founding Date
2002
Founding Date
2002
Founding Date
2005
Type
Type
Private
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Dublin, IE HQ
Dublin, IE
Locations
Boston, US HQ
Locations
San Clemente, US HQ
San Clemente, US
Locations
San Carlos, US HQ
Locations
Rockaway, US HQ
Parksville, CA
Geretsried, DE
Hamburg, DE
Yeadon, GB
Bernards, US
Employees
Employees
838% increase
Employees
6810% increase
Employees
4348% decrease
Employees
2713% increase
Employees
5144% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
3 m
Valuation ($)
8.5 m
Valuation ($)
71.2 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$11.3m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$32m (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$5m (FY, 2020)
Cost of goods
N/A
Cost of goods
$4.2m (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$6.3m (FY, 2020)
Gross profit
N/A
Gross profit
$27.8m (FY, 2025)
Net income
Net income
N/A
Net income
($63m) (FY, 2022)
Net income
($21.6m) (FY, 2020)
Net income
($8.2m) (FY, 2025)
Net income
($14m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 7.5m
Total funding raised
$ 189m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 127m
For sources of this data, please see the company profile

View Company Profiles

Decibel Therapeutics
HQ
Boston, US

Decibel Therapeutics is a biotechnology company that discovers and develops transformative treatments to restore and improve hearing and balance.

View company
ReShape Lifesciences
HQ
San Clemente, US
Employees
43↓ 48% decrease

ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.

View company
BioCardia
HQ
San Carlos, US
Employees
27↑ 13% increase

BioCardia is a clinical-stage regenerative medicine company.

View company
ElectroCore
HQ
Rockaway, US
Employees
51↓ 44% decrease

ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.

View company